Who
Scott Sukenick
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, Scynexis.
In numbers
- Trades disclosed
- 27
- Buys
- 3
- Sells
- 0
- Bought
- $26K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Nov 2017
- Last trade
- 29 Jan 2026
- Last filed
- 2 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jan 2026filed 2 Feb 2026 | SCYX ScynexisBiotechnology | SEC FORM 4 Code A | —129,833 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | SCYX ScynexisBiotechnology | SEC FORM 4 Code A | —129,833 at $0.00 | filing |
| 23 Jan 2025filed 27 Jan 2025 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —138,767 at $0.00 | filing |
| 23 Jan 2025filed 27 Jan 2025 | SCYX ScynexisBiotechnology | SEC FORM 4 Code A | —92,511 at $0.00 | filing |
| 16 Feb 2024filed 16 Feb 2024 | SCYX ScynexisBiotechnology | SEC FORM 4 Code F | $25K15,179 at $1.63 | filing |
| 26 Jan 2024filed 30 Jan 2024 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —215,515 at $0.00 | filing |
| 26 Jan 2024filed 30 Jan 2024 | SCYX ScynexisBiotechnology | SEC FORM 4 Code A | —143,675 at $0.00 | filing |
| 15 May 2023filed 17 May 2023 | SCYX ScynexisBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 27 Jan 2023filed 31 Jan 2023 | SCYX ScynexisBiotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 26 Apr 2022filed 28 Apr 2022 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,500 at $0.00 | filing |
| 26 Apr 2022filed 28 Apr 2022 | SCYX ScynexisBiotechnology | SEC FORM 4 Bought | $11K3,500 at $3.00 | filing |
| 4 Feb 2022filed 8 Feb 2022 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 4 Feb 2022filed 8 Feb 2022 | SCYX ScynexisBiotechnology | SEC FORM 4 Code A | —40,700 at $0.00 | filing |
| 29 Jan 2021filed 2 Feb 2021 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 21 Dec 2020filed 23 Dec 2020 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —800 | filing |
| 21 Dec 2020filed 23 Dec 2020 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —800 | filing |
| 21 Dec 2020filed 23 Dec 2020 | SCYX ScynexisBiotechnology | SEC FORM 4 Bought | $10K1,600 at $6.25 | filing |
| 25 Nov 2020filed 4 Dec 2020 | SCYX ScynexisBiotechnology | SEC FORM 4 Code F | $18K2,613 at $6.81 | filing |
| 15 Feb 2020filed 4 Dec 2020 | SCYX ScynexisBiotechnology | SEC FORM 4 Code F | $7,673783 at $9.80 | filing |
| 31 Jan 2020filed 4 Feb 2020 | SCYX Scynexisoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.